JAMES A. GERAGHTY - 23 Jun 2022 Form 4 Insider Report for IDERA PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ James A. Geraghty
Issuer symbol
N/A
Transactions as of
23 Jun 2022
Net transactions value
$0
Form type
4
Filing time
27 Jun 2022, 16:30:39 UTC
Previous filing
24 Jun 2022
Next filing
29 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDRA Stock Option (Right to Buy) Award $0 +26,000 $0.000000 26,000 23 Jun 2022 Common Stock 26,000 $0.4561 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Non-qualified stock options granted, under the Issuer's 2013 Stock Incentive Plan, on the date of the Issuer's 2022 annual meeting of stockholders at an exercise price equal to the closing price of the Issuer's common stock on the date of grant, pursuant to the Issuer's director compensation policy.
F2 The options vest in full and become immediately exercisable on June 23, 2023 (first anniversary of the date of grant), subject to continued service as a director of the Issuer.